TRILEPTAL 60 mg/ml ORAL SUSPENSION

2. What you need to know before you take Trileptal

Follow carefully all instructions given by your doctor, even if they differ from the general information provided in this leaflet.

Monitoring during treatment with Trileptal

Before and during treatment with Trileptal, your doctor may perform a blood test to determine your dose. Your doctor will tell you when to have the tests.

Do not take Trileptal:

• if you are allergic to oxcarbazepine or any of the other ingredients of this medicine (listed in section 6) or if you are allergic to eslicarbazepine.

If you are allergic, inform your doctor before taking Trileptal. If you think you are allergic, ask your doctor.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Trileptal:

• if you have ever suffered from any unusual allergic reaction(rash or any other type of allergy) to carbamazepine or any other medicine. If you are allergic to carbamazepine, the likelihood of you being allergic to oxcarbazepine (Trileptal) is 1 in 4 (25%).
• if you have kidney disease.
• if you have severe liver disease.
• if you are taking diuretics(medicines to help the kidneys eliminate salt and water by increasing urine production).
• if you have heart disease, shortness of breath and/or swelling of feet or legs due to fluid retention.
• if your blood sodium level is lowas shown by your blood test (see section 4).
• if you are a woman taking oral contraceptives(such as the pill), Trileptal may make the contraceptive not work. Use a non-hormonal contraceptive method or an extra one while taking Trileptal. This can help prevent an unwanted pregnancy. Inform your doctor immediately if you have irregular vaginal bleeding or spotting. If you have any doubts about this, consult your doctor or healthcare professional before taking Trileptal.

The risk of serious skin reactions in Han Chinese or Thai patients associated with carbamazepine or chemically related compounds can be predicted by blood tests. Your doctor will advise you if a blood test is necessary before taking oxcarbazepine.

If you notice any of the following symptoms after taking Trileptal, inform your doctor immediately or go to the Emergency Department of the nearest hospital:

• if during treatment you suffer an allergic reaction. Symptoms include swelling of lips, eyelids, face, throat, mouth, or sudden respiratory problems, fever with swollen lymph nodes, rash, or blisters on the skin.
• if you notice symptoms suggesting hepatitis, such as jaundice (yellowing of the skin or the white of the eyes).
• if you notice an increase in the frequency of seizures. This is especially important in children, but it can also occur in adults.
• if you notice possible symptoms of blood disorderssuch as fatigue, shortness of breath when exercising, paleness, headache, chills, dizziness, frequent infections with fever, sore throat, mouth ulcers, bleeding or bruising more often than usual, nosebleeds, red or purple spots, or spontaneous appearance of spots on the skin.
• a small number of people treated with antiepileptics like Trileptal have had thoughts of self-harm or suicide. If at any time you experience these thoughts, contact your doctor immediately.
• if you notice that your heart rate is fast or unusually slow.

• Children and adolescents

For treatment in children, your doctor may recommend monitoring thyroid function before and during treatment.

Using Trileptal with other medicines:

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Especially in the case of:

• Oral contraceptives such as the pill (see section Warnings and precautions).
• Other antiepileptic medicines and enzyme-inducing medicines such as carbamazepine, phenobarbital, phenytoin, or lamotrigine and rifampicin.
• Medicines that reduce blood sodium levels, such as diuretics (used to help the kidneys eliminate salt and water by increasing urine production), desmopressin, and non-steroidal anti-inflammatory medicines such as indomethacin.
• Lithium and monoamine oxidase inhibitors (medicines used to treat mood disorders and some types of depression).
• Medicines that control the body's immune system such as cyclosporin and tacrolimus.

Taking Trileptal with food and alcohol

Trileptal can be taken with or without food. During treatment with Trileptal, avoid drinking alcoholic beverages as it may increase the sedative effects of this medicine; if in doubt, consult your doctor.

Pregnancy and breastfeeding

Pregnancy

If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

It is essential to control epileptic seizures during pregnancy. However, there may be a risk to your baby if you take antiepileptic medicines during pregnancy.

Congenital malformations

Studies have not shown an increased risk of congenital malformations associated with oxcarbazepine administered during pregnancy; however, it cannot be entirely ruled out that there is a risk of congenital malformations in the fetus.

Neurodevelopmental disorders

Some studies have shown that exposure to oxcarbazepine in the womb affects the development of brain function (neurodevelopment) in children, while others have not observed this effect. The possibility that there may be an effect on neurodevelopment cannot be ruled out.

Your doctor will inform you of the benefits and possible risks of treatment and help you decide whether you should take Trileptal.

Do not stop your treatment with Trileptal during pregnancy without first consulting your doctor.

Breastfeeding

If you are taking this medicine, consult your doctor before starting breastfeeding. The active substance of Trileptal passes into breast milk. Although the available data suggest that the amount of Trileptal that passes to the breastfed child is low, a risk of adverse effects in the baby cannot be ruled out. Your doctor will inform you of the benefits and potential risks of breastfeeding while using Trileptal. If you are breastfeeding during treatment with Trileptal and think your baby is experiencing any adverse effects such as excessive sleepiness or poor weight gain, inform your doctor immediately.

Driving and using machines

Trileptal can cause symptoms such as drowsiness, dizziness, or changes in vision, and reduce your reaction ability. These effects, as well as the disease itself, can make it difficult for you to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medicine.

It is essential to consult your doctor if you can drive or operate machines while taking this medicine.

Trileptal contains sorbitol (E420), propylene glycol (E1520), parahydroxybenzoates, sodium, and ethanol

Trileptal oral suspension contains:

• Sorbitol (E420): This medicine contains 175 mg of sorbitol in each 1 ml of oral suspension.

Sorbitol is a source of fructose. If your doctor has told you (or your child) that you have an intolerance to certain sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine.

Sorbitol can cause gastrointestinal upset and a mild laxative effect.

• Propylene glycol (E1520): this medicine contains 25 mg of propylene glycol in each 1 ml of oral suspension.
• Parahydroxybenzoates: propyl parahydroxybenzoate (E216) and methyl parahydroxybenzoate (E218), which may cause allergic reactions (possibly delayed).
• Sodium: this medicine contains less than 1 mmol of sodium (23 mg) per 1 ml; this is, essentially "sodium-free".

• Etanol: This medicine contains 0.8 mg of alcohol (ethanol) in each 1 ml of oral suspension. The amount in 1 ml of this medicine is equivalent to less than 0.02 ml of beer or 0.01 ml of wine. The small amount of alcohol in this medicine does not produce any noticeable effect.

3. How to take Trileptal

Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The dose must be indicated in milliliters (ml)

The dose prescribed by your doctor must be indicated in milliliters (ml)and not in milligrams (mg). This is important because the oral dosing syringe used to extract the correct dose from the bottle is marked in milliliters. If your prescription is in milligrams, do not take the medicine and consult your doctor or pharmacist as soon as possible.

How much to take

Use in adults

• The recommended dosefor adults (including elderly patients) is 10 ml of oral suspension (600 mg of oxcarbazepine) per day.
• Take a dose of 5 ml of oral suspension (300 mg of oxcarbazepine) twice a day.
• Your doctor may gradually increase this dose to obtain the best dose for you. The best results are usually with doses between 10 ml and 40 ml of oral suspension (600 mg of oxcarbazepine to 2,400 mg of oxcarbazepine) per day.
• The dose is the same if Trileptal is taken with another antiepileptic medicine.
• If you have kidney problems (renal insufficiency), the initial dose is half the normal initial dose.
• If you have severe liver disease, your doctor will adjust the dose.

Use in children and adolescents

Trileptal can be used in children aged 6 years or older.

The recommended dose for children will be calculated by the doctor and depends on the child's weight.

• The initial dose is 8 to 10 milligrams per kilogram of body weight per day, administered in two doses. For example, a 30 kg child will start treatment with a dose of 150 mg (2.5 ml of oral suspension) twice a day.
• Your doctor may gradually increase the dose to obtain the best dose for the child. The best results are usually with a dose of 30 milligrams per kilogram of body weight per day. The maximum dose for a child is 46 milligrams per kilogram of body weight per day.

How to take Trileptal

For complete instructions on how to take Trileptal, see the Instructions for usesection at the end of this leaflet.

When and for how long to take Trileptal

Take Trileptal twice a day, every day, approximately at the same time of day, unless your doctor tells you otherwise. This will have the best effect to control epilepsy. It will also help you remember when to take the oral suspension.

Your doctor will inform you how long your treatment or your child's treatment will last. The duration of treatment will depend on the type of seizures you or your child suffer from. It may be necessary to continue treatment for several years to control epileptic seizures. Do not change the dose or stop treatment without first talking to your doctor.

If you take more Trileptal than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. The symptoms of overdose with Trileptal may include:

• drowsiness, dizziness, coordination problems and/or involuntary eye movements, muscle contractions, or significant worsening of seizures, headache, loss of consciousness, coma,
• nausea, vomiting, increased uncontrolled movements,
• numbness, double vision, decreased pupil size or constriction, blurred vision,
• fatigue,
• short, shallow, and rapid breathing (respiratory depression),
• irregular heartbeat (prolonged QTc interval),
• tremor, headache, coma, decreased level of consciousness, uncontrolled movements of the mouth, tongue, and limbs,
• aggression, agitation, confusion,
• low blood pressure,
• breathing difficulties.

If you forget to take Trileptal

If you have forgotten a dose, take it as soon as you can, except if it is almost time for the next dose; in this case, wait and return to your usual administration schedule. Do not take a double dose to make up for forgotten doses.

If you are unsure or have forgotten several doses, inform your doctor.

If you stop taking Trileptal

Do not stop taking your medicine without first consulting your doctor.

To prevent a sudden worsening of seizures, do not stop treatment abruptly.

If you stop your treatment, it should be done gradually as indicated by your doctor.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Inform your doctor immediately or go to the emergency department of the nearest hospital if you experience any of the following adverse effects:

The following are symptoms of potentially serious adverse effects that may require urgent medical treatment.

Your doctor will decide whether to immediately discontinue treatment with Trileptal and how to continue your treatment in the future.

Uncommon(may affect up to 1 in 100 patients):

• Weight gain, fatigue, hair loss, muscle weakness, feeling of cold (signs of low thyroid activity).
• Falls

Rare(may affect up to 1 in 1,000 patients):

• Inflammation of the lips, eyelids, face, throat, or mouth, accompanied by difficulty breathing, speaking, or swallowing (signs of anaphylactic reactions and angioedema).
• Skin rash and/or fever, which can be manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS), or acute generalized exanthematous pustulosis (AGEP).
• Fatigue, shortness of breath when exercising, paleness, headache, chills, dizziness, frequent infections with fever, sore throat, mouth ulcers, bleeding, or bruising more often than usual, nosebleeds, reddish-purple spots, or spontaneous appearance of spots on the skin (signs of a decrease in the number of platelets or a decrease in the number of blood cells).
• Numbness, confusion, muscle contractions, or significant worsening of seizures (possible symptoms of low sodium levels in the blood due to inadequate secretion of antidiuretic hormone (ADH)) (see Warnings and Precautions section).

Very Rare(may affect up to 1 in 10,000 patients):

• Signs of hypersensitivity reactions (allergy) such as skin rash, fever, and pain in the muscles and joints.
• Severe blistering of the skin and/or mucous membranes of the lips, eyes, mouth, nasal passages, or genitals (signs of severe allergic reaction, including Lyell's syndrome, Stevens-Johnson syndrome, and erythema multiforme).
• Rash with red spots mainly on the face, which may be accompanied by fatigue, fever, feeling of dizziness (nausea), or loss of appetite (sign of systemic lupus erythematosus).
• Flu-like symptoms with jaundice (yellowing of the skin and the whites of the eyes) (signs of hepatitis).
• Severe upper abdominal pain, nausea (vomiting), loss of appetite (signs of pancreatitis).

Inform your doctor as soon as possible if you experience any of the following adverse effects.They may require medical attention:

Common(may affect up to 1 in 10 patients):

• Tremors, coordination problems, involuntary eye movements, anxiety, and nervousness, depression, mood changes, skin rash.

Very Rare(may affect up to 1 in 10,000 patients):

• Irregular heartbeat or a very fast or slow heartbeat.

Other Adverse Effects that May Occur:

These are mild to moderate adverse effects of Trileptal. Most of these effects are temporary and usually decrease over time.

Very Common(may affect more than 1 in 10 patients):

• Fatigue, headache, dizziness, drowsiness, feeling of dizziness (nausea), nausea (vomiting), and double vision.

Common(may affect up to 1 in 10 patients):

• Weakness, memory disorders, difficulty concentrating, apathy, agitation, confusion, blurred vision, constipation, diarrhea, abdominal pain, acne, hair loss, vertigo, weight gain, speech disorders.

Uncommon(may affect up to 1 in 100 patients):

• High blood pressure (hypertension), hives.
• Liver enzyme levels may also increase while taking Trileptal.

Rare(may affect up to 1 in 1,000 patients):

• Reports of bone disorders, including osteopenia and osteoporosis (decrease in bone mass), and fractures. Inform your doctor or pharmacist if you have been taking antiepileptics for a long time, have a medical history of osteoporosis, or are taking steroids.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Trileptal

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.

Once the packaging is opened, use it within the following 7 weeks.

After 7 weeks, return the unused oral suspension to your pharmacy for safe disposal.

Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.

Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Packaging Contents and Additional Information

Composition of Trileptal

• The active ingredient is oxcarbazepine. Each ml of oral suspension contains 60 mg of oxcarbazepine.
• The other components (excipients) are: purified water, sorbitol (E420) 70% (non-crystallizing), propylene glycol (E1520), dispersible cellulose, ascorbic acid (E300), lemon plum flavor (contains ethanol), methyl parahydroxybenzoate (E218), macrogol 400 stearate, sorbic acid (E200), sodium saccharin, propyl parahydroxybenzoate (E216).

Appearance of the Product and Packaging Contents

Trileptal oral suspension is presented as a whitish suspension that tends to a reddish-brown color. The discoloration of the oral suspension to a slightly reddish-brown color is normal and does not affect the quality of the product.

Trileptal oral suspension is presented in amber glass bottles containing 250 ml of oral suspension. The bottles come with a child-resistant cap, a 10 ml dosing syringe, and a bottle adapter.

Marketing Authorization Holder and Manufacturer

Novartis Farmacéutica, S.A.

Gran Vía de les Corts Catalanes, 764

08013 Barcelona

Spain

Manufacturer

Novartis Pharma GmbH

Roonstrasse 25 (Nuremberg)

D-90429 – Germany

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

Nuremberg 90443

Germany

Novartis Farmacéutica, S.A. Gran Vía de les Corts Catalanes, 764, 08013 Barcelona Spain

This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Austria: Trileptal

Belgium: Trileptal

Croatia: Trileptal

Denmark: Trileptal

Finland: Trileptal

France: Trileptal

Germany: Trileptal

Greece: Trileptal

Iceland: Trileptal

Ireland: Trileptal

Netherlands: Trileptal

Portugal: Trileptal

Spain: Trileptal

Sweden: Trileptal

United Kingdom (Northern Ireland): Trileptal

Date of the last revision of this prospectus:March 2023

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

_____________________________________________________________________________

Página 1

INSTRUCTIONS FOR USE

Please read these instructions carefully to know how to use this medicine

How to use the medicine kit

The medicine kit consists of three parts

Página 2

How to adjust the plastic adapter on a new medicine bottle

Página 3

Preparing a dose of medicine